NEXTBio Capital Management LP
Q4 2025 13F Holdings
- Locationmenlo park, CA
- Num holdings
23
- Value ($000)
$170,492
- Date Filed02/13/2026
- Form type13F-HR
- CIK0002038158
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
TERNS PHARMACEUTICALS INC | COM | 880881107 | $22.27M | 13 % | 551,190 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $20.05M | 12 % | 229,619 | ||
VOR BIOPHARMA INC | COM NEW | 929033207 | $13.08M | 8 % | 999,967 | ||
ZENAS BIOPHARMA INC | COM | 98937L105 | $11.69M | 7 % | 321,983 | ||
SHATTUCK LABS INC | COM | 82024L103 | $11.5M | 7 % | 3,149,907 | ||
VERASTEM INC | COM NEW | 92337C203 | $10.09M | 6 % | 1,307,330 | ||
PALVELLA THERAPEUTICS INC NE | COM | 697947109 | $8.65M | 5 % | 82,686 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | $8.23M | 5 % | 183,704 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $7.23M | 4 % | 67,586 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | $6.57M | 4 % | 94,443 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100